These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12829196)

  • 1. Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins.
    Dzeka TN; Townley R; Arnold JM
    Cardiovasc Res; 2003 Jul; 59(1):250-6. PubMed ID: 12829196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct angiotensin converting enzyme inhibitor-mediated venodilation.
    Zarnke KB; Feldman RD
    Clin Pharmacol Ther; 1996 May; 59(5):559-68. PubMed ID: 8646827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Chalon S; Moreno H; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous responsiveness to norepinephrine in healthy subjects: effects of single doses of 325 mg aspirin.
    Dzeka TN; Kuzminski P; Arnold JM
    Clin Pharmacol Ther; 2000 Mar; 67(3):299-304. PubMed ID: 10741634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties.
    Eichler HG; Blöchl-Daum B; Kyrle PA; Gasic S
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):248-52. PubMed ID: 2476598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
    Paula RD; Lima CV; Khosla MC; Santos RA
    Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin modulation of venoconstriction to physiological stress in normals and heart failure patients.
    Dzeka TN; Arnold JM
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H790-7. PubMed ID: 12578811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
    Padmanabhan N; Jardine AG; McGrath JC; Connell JM
    Circulation; 1999 Jun; 99(22):2914-20. PubMed ID: 10359736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys.
    Lotti VJ; Pawlowski N
    J Ocul Pharmacol; 1990; 6(1):1-7. PubMed ID: 2163428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.
    Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
    Hypertension; 2014 May; 63(5):951-7. PubMed ID: 24516103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced in vivo alpha1- and alpha2-adrenoceptor-mediated venoconstriction with indomethacin in humans.
    Callow ID; Campisi P; Lambert ML; Feng Q; Arnold JM
    Am J Physiol; 1998 Sep; 275(3):H837-43. PubMed ID: 9724287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of systemically given placebo, trapidil and isosorbide dinitrate on norepinephrine-evoked hand vein constriction in healthy subjects.
    Sziegoleit W; Dannenberg K; Konschak A; Lautenschläger C; Presek P
    Arzneimittelforschung; 2007; 57(2):81-6. PubMed ID: 17396617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans.
    Masumori S; Newby DE; Strachan FE; Boon NA; Webb DJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):327-33. PubMed ID: 9333109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
    Houben AJ; Kroon AA; de Haan CH; Fuss-Lejeune MJ; de Leeuw PW
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):657-63. PubMed ID: 11300367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man.
    Cziraki A; Horvath I; Rubin JW; Theodorakis M; Catravas JD
    Gen Pharmacol; 2000 Oct; 35(4):213-8. PubMed ID: 11827728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.